DPYSL2 and Alzheimer disease: Furthermore, to determine changes in site-specific phosphorylation, three phosphorylation sites of CRMP2 that have been previously reported to be hyperphosphorylated in AD patients were selected (Thr514, Ser522 and Thr555) [46].